| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Thomas D. Zindrick
Also a director
President, Chief Executive Officer and Chairman
|
67 | Not stated | $4,277,083 | |
|
Matthew Pulisic
Chief Financial Officer
|
42 |
Since 2025
1 year
|
$1,487,011 | |
|
Jason Litten
Chief Medical Officer
|
52 |
Since 2026
this year
|
Not reported | |
|
Joseph Cappello
Chief Technical Officer
|
69 |
Since 2023
3 years
|
$1,442,092 | |
|
Eric Groen
General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
|
55 |
Since 2025
1 year
|
Not reported | |
|
Yong Yu
Chief Scientific Officer
Title from the Form 4 dated Nov 3, 2026
|
Not stated | Not stated | Not reported | |
|
Tony Yu
Senior Vice President, Clinical Development
|
55 |
Since 2023
3 years
|
Not reported | |
|
Ralph Smalling
Head of Regulatory
|
70 |
Since 2023
3 years
|
Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 29, 2026 states there were none.
Read it in the proxyLoading...